Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-Aventis, a pharmaceutical company, has signed a three-year contract to extend the use of Advanced Chemistry Development's software throughout its R&D sites worldwide. The agreement includes provisions for continuing support, and a special pricing structure beneficial to both companies.
Subscribe to our email newsletter
Sanofi-Aventis uses a range of Advanced Chemistry Development’s (ACD/Labs) analytical, predictive, and nomenclature tools such as ACD/SpecManager, ACD/Structure Design Suite, ACD/PhysChem Batch predictors, and ACD/Name.
Additional support provided under the new agreement will encourage greater adoption of these tools within all R&D sites, in particular in Europe and the USA. The new contract provides a special pricing model for the company based on the level of deployment throughout the various sites.
Yves Lorrain, director of sales for Chemcad-a distributor of products at ACD/Labs, said: “Sanofi-Aventis has been using ACD/Labs tools in its R&D groups throughout the organization for more than five years.
“With this contract we will continue to provide the same high level of support and allow Sanofi-Aventis R&D scientists to maximize the intrinsic value of each of the ACD/Labs modules they use.”